Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Final Trades: Uber, URNM, Abbott Labs and Vertex Pharma
02:00pm, Thursday, 11'th Jan 2024
Brenda Vingiello, Sand Hill Global Advisors CIO, Bryn Talkington, Requisite Capital Management managing partner, Jim Lebenthal, Cerity Partners chief equity strategist, and Josh Brown, Ritholtz Wealth
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
07:37pm, Tuesday, 09'th Jan 2024
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $421.01, indicating a +0.45% shift from the previous trading day.
Vertex Pharmaceuticals Incorporated (VRTX) J.P. Morgan 42nd Annual Healthcare Conference
01:39pm, Monday, 08'th Jan 2024
Vertex Pharmaceuticals Incorporated (VRTX) J.P. Morgan 42nd Annual Healthcare Conference
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?
01:32pm, Monday, 08'th Jan 2024
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PBYI vs. VRTX: Which Stock Is the Better Value Option?
12:47pm, Monday, 08'th Jan 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech (PBYI) and Vertex Pharmaceuticals (VRTX). But which of these two stocks offers value investors a
2 low-priced gene therapy stocks to speculate on
08:26am, Monday, 08'th Jan 2024
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences.
Is Vertex Pharmaceuticals Stock a Buy Now?
08:45am, Saturday, 06'th Jan 2024
Vertex has a huge competitive advantage in its core franchise, where it still has room to grow. It's also developing new medicines elsewhere and recently landed an important approval.
2 Biotech Stocks With Huge Catalysts in 2024
05:34am, Friday, 05'th Jan 2024
Vertex Pharmaceuticals' cystic fibrosis franchise is successful, but it's also running out of room to grow. Expected results from a trial with an experimental pain reliever called VX-548 could push Ve
Gen Z's Top Picks for 2024: 7 Trending Stocks Among Young Investors
12:54pm, Thursday, 04'th Jan 2024
Gen Z stocks aren't typical, because the generation has a unique relationship with the stock market. Just like Gen Z is the first to grow up fully immersed in digitization and the Internet culture, ac
3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition
12:17pm, Wednesday, 03'rd Jan 2024
Betting on healthcare's future via healthcare stocks is one of the safest long-term bets you can make. Though changes and advances happen rapidly, healthcare is one industry that is here to stay.
3 Biotech Stocks Set for Breakthroughs in 2024
01:34pm, Tuesday, 02'nd Jan 2024
As we break into the new year, investors are on the hunt for the best biotech stocks to buy. Indeed, 2024 could witness groundbreaking advancements in technology and science.
2 gene-editing stocks reshaping hereditary disease treatments
07:16am, Tuesday, 02'nd Jan 2024
Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal Drug Administration (FDA) approved a sickle
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
10:30am, Sunday, 31'st Dec 2023
Cathie Wood has purchased a large stake in CRISPR Therapeutics for her ARK Invest ETFs. The company won a landmark regulatory approval this year, but analysts think the therapy may get off to a slow s
2 Exceptional Growth Stocks Up 42% and 66% to Buy Right Now
07:00am, Friday, 29'th Dec 2023
Healthcare and travel spending remain at all-time highs. Vertex just hit another huge business milestone.
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
07:35pm, Thursday, 28'th Dec 2023
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $409.27, indicating a +0.3% shift from the previous trading day.
